During the past decade, Seoul National University Children's Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University Children's Hospital" #1 sponsor was "Seoul National University Hospital" with 17 trials, followed by "Seoul National University Childrens Hospital" with 3 trials sponsored, "Mezzion Pharma Co. Ltd" with 2 trials sponsored, "Albireo" with 1 trials sponsored and "BioMarin Pharmaceutical" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University Children's Hospital" #1 collaborator was "Ajou University School of Medicine" with 2 trials as a collaborator, "Ministry of Food and Drug Safety, Korea" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Severance Hospital" with 2 trials as a collaborator and "Alberta Children's Hospital" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University Children's Hospital" are "Acute Kidney Injury" (2 trials), "Infant, Preterm" (2 trials), "Neonates and Preterm Infants" (2 trials), "Preterm Infants" (2 trials) and "Very Low Birth Weight Infant" (2 trials). Many other conditions were trialed in "Seoul National University Children's Hospital" in a lesser frequency.

Most popular intervention types in "Seoul National University Children's Hospital" are "Drug" (17 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Losartan" (2 trials), "Udenafil" (2 trials), "Clarithromycin" (1 trials) and "Dopamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University Children's Hospital" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Seoul National University Children's Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 14 completed trials in Seoul National University Children's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University Children's Hospital, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".